GI Medical Calculator 與 Hypercholesterolemia 使用情況與統計

GI Medical Calculator App is an application that conducts accessible and instant calculations of various laboratory results. This medical calculator is an innovative tool to help doctors deliver automated computations of the patients’ laboratory results.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

@Point of Care™ with Cognitive AI is a clinical decision-making mobile platform. Hypercholesterolemia @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Hypercholesterolemia @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Hypercholesterolemia content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

GI Medical Calculator與 Hypercholesterolemia 比較排名

比較過去 28 天的 GI Medical Calculator 排名趨勢與 Hypercholesterolemia

排名

無可用數據

各國 GI Medical Calculator vs. Hypercholesterolemia 排名比較

比較過去 28 天的 GI Medical Calculator 排名趨勢與 Hypercholesterolemia

無可顯示數據

使用我們的免費試用版,與所有網站進行比較

立即開始
GI Medical Calculator VS.
Hypercholesterolemia

12月 17, 2024